Viewing Study NCT02032433


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-03-03 @ 6:29 AM
Study NCT ID: NCT02032433
Status: COMPLETED
Last Update Posted: 2020-08-13
First Post: 2013-12-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
Sponsor: NYU Langone Health
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Opioid Use Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None extended-release naltrexone (Vivitrol) View
None buprenorphine-naloxone (Suboxone) View
None comparative effective View
None relapse prevention View